Meeting
2019 ASCO Annual Meeting
The Circulating Cell-free Genome Atlas (CCGA) Study: Size selection of cell-free DNA (cfDNA) fragments.
Authors
Darya Filippova
GRAIL, Inc., Menlo Park, CA
Darya Filippova , Matthew H. Larson , M. Cyrus Maher , Robert Calef , Monica Pimentel , Yiqi Zhou , Joshua Newman , Samuel Gross , Virgil Nicula , Ting-Chun Liu , Christopher Yakym , Jennifer Berman , Alex Aravanis , Arash Jamshidi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics and Tumor Biology (Nonimmuno)
Track
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Sub Track
New Targets and New Technologies (non-IO)
Clinical Trial Registration Number
NCT02889978
Citation
J Clin Oncol 37, 2019 (suppl; abstr 3103)
DOI
10.1200/JCO.2019.37.15_suppl.3103
Abstract #
3103
Poster Bd #
95
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Tumor methylation patterns to measure tumor fraction in cell-free DNA.
First Author: Colin Melton
Poster
2019 ASCO Annual Meeting
The Circulating Cell-free Genome Atlas (CCGA) Study: Follow-up (F/U) on non-cancer participants with cancer-like cell-free DNA signals.
First Author: Allen Lee Cohn
Poster
2018 ASCO Annual Meeting
Development of a comprehensive cell-free DNA (cfDNA) assay for early detection of multiple tumor types: The Circulating Cell-free Genome Atlas (CCGA) study.
First Author: Eric A. Klein
Poster
2021 ASCO Annual Meeting
Detection of cancer signal for over 50 AJCC cancer types with a multi-cancer early-detection test.
First Author: Habte Aragaw Yimer